Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience

• Published in: BJU international Vol. 110; no. 11; pp. 1767 - 1774
• Main Authors: Wagg, Adrian, Compion, Gerhard, Fahey, Amanda, Siddiqui, Emad
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.12.2012; Wiley-Blackwell; Wiley Subscription Services, Inc
• Subjects: Administration, Oral; Adult; Age Factors; antimuscarinic drugs; Biological and medical sciences; Bladder; Chronic Disease; Female; Humans; Longitudinal Studies; Male; Medical sciences; Medication Adherence - statistics & numerical data; Middle Aged; Muscarinic Antagonists - administration & dosage; Nephrology. Urinary tract diseases; overactive bladder; Patients; persistence; Prescription Drugs - administration & dosage; solifenacin; United Kingdom; Urinary Bladder, Overactive - drug therapy; Urinary incontinence; Urinary system involvement in other diseases. Miscellaneous; Urinary tract. Prostate gland; United Kingdom; Europe; Drug; Nephrology; Urinary system disease; Urinary tract disease; Urology; Persistence; Anticholinergic agent; Cholinergic receptor; Treatment; Solifenacin; Antimuscarinic agent; Overactive bladder; Bladder disease; Muscarinic receptor; Antagonist; antimuscarinic drugs

Study Type – Therapy (prevalence) Level of Evidence 2b What's known on the subject? and What does the study add? Persistence with long‐term medication in chronic diseases is typically low and that for overactive bladder medication is lower than average. Sub‐optimal persistence is a major challe...